Equity Overview
Price & Market Data
Price: $0.0429
Daily Change: -$0.0104 / 24.24%
Daily Range: $0.0429 - $0.0533
Market Cap: $109,726,568
Daily Volume: 20,500
Performance Metrics
1 Week: -52.33%
1 Month: -39.32%
3 Months: -25.39%
6 Months: -54.12%
1 Year: -86.59%
YTD: -52.07%
Details
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.